Grifols Shared Services North America, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.2Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
504clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $204K
2020 $149K
2021 $67K
2022 $121K
2023 $222K
2024 $80K
2025 $403K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurology (Psychiatry & Neurology) $203K
Anesthesiology $173K
Pulmonary Disease $143K
Blood Banking & Transfusion Medicine $87K
Hematology & Oncology $53K
Allergy & Immunology $51K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Edward Garmey New York, NY $143,150.00
Karthik Raghunathan Durham, NC Anesthesiology $123,200.00
Zbigniew Szczepiorkowski Lebanon, NH Blood Banking & Transfusion Medicine $72,050.23
Richard Lipton Bronx, NY Neurology (Psychiatry & Neurology) $70,255.50
Jerrold Levy Durham, NC Anesthesiology $26,427.90
Alireza Atri Boston, MA Neurological Surgery $26,035.51
Alex Spyropoulos Rochester, NY Hematology & Oncology $21,030.49
Samuel Goldman San Francisco, CA Preventive Medicine/Occupational Environmental Medicine $21,000.00
Gregory Martin Atlanta, GA Pulmonary Disease $20,709.45
Antoine Azar Baltimore, MD Allergy & Immunology (Internal Medicine) $17,578.38

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.